Bioharvest Sciences (BHST) Cash from Financing Activities (2023 - 2025)

Bioharvest Sciences' Cash from Financing Activities history runs 3 years deep, the most recent figure standing at $14.9 million for Q4 2025.

• In Q4 2025, Cash from Financing Activities rose 508.92% year-over-year to $14.9 million; the TTM figure through Dec 2025 stood at $30.2 million (up 345.24% YoY), while the FY2025 annual figure was $30.2 million, up 345.24% from the prior year.
• Cash from Financing Activities for Q4 2025 stood at $14.9 million, up from $9.7 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $14.9 million in Q4 2025, with the low at -$164000.0 in Q3 2024.
• The 3-year median for Cash from Financing Activities is $2.8 million (2024), against an average of $4.5 million.
• The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities sank 113.86% in 2024, then surged 6036.59% in 2025.
• Bioharvest Sciences' Cash from Financing Activities stood at $7.0 million in 2023, then sank by 64.99% to $2.5 million in 2024, then jumped by 508.92% to $14.9 million in 2025.
• Business Quant data shows BHST's Cash from Financing Activities at $14.9 million in Q4 2025, $9.7 million in Q3 2025, and $2.4 million in Q2 2025.